Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
STSS logo STSS
Upturn stock rating
STSS logo

Sharps Technology Inc (STSS)

Upturn stock rating
$5.58
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/15/2025: STSS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $22

1 Year Target Price $22

Analysts Price Target For last 52 week
$22 Target price
52w Low $3.36
Current$5.58
52w High $1248.27

Analysis of Past Performance

Type Stock
Historic Profit -47.46%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/15/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 134.60M USD
Price to earnings Ratio -
1Y Target Price 22
Price to earnings Ratio -
1Y Target Price 22
Volume (30-day avg) 1
Beta 2.16
52 Weeks Range 3.36 - 1248.27
Updated Date 10/17/2025
52 Weeks Range 3.36 - 1248.27
Updated Date 10/17/2025
Dividends yield (FY) -
Basic EPS (TTM) -1196.84

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1349.84%

Management Effectiveness

Return on Assets (TTM) -50.38%
Return on Equity (TTM) -6.65%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 182455305
Price to Sales(TTM) 604.34
Enterprise Value 182455305
Price to Sales(TTM) 604.34
Enterprise Value to Revenue 819.21
Enterprise Value to EBITDA -2.19
Shares Outstanding 26600848
Shares Floating 1021853
Shares Outstanding 26600848
Shares Floating 1021853
Percent Insiders 0.13
Percent Institutions 0.07

ai summary icon Upturn AI SWOT

Sharps Technology Inc

stock logo

Company Overview

overview logo History and Background

Sharps Technology Inc. focuses on the design, development, and manufacturing of safety syringe products. It aims to reduce needlestick injuries and prevent cross-contamination in healthcare settings. The company has been involved in the development of various safety-engineered medical devices.

business area logo Core Business Areas

  • Safety Syringes: Design, manufacturing, and sale of ultra-low waste space safety syringes. These syringes are designed to minimize medication waste and reduce the risk of needlestick injuries and cross-contamination. Target market are clinicians and drug manufacturers for prefilled syringes and vaccine delivery.

leadership logo Leadership and Structure

Details on the specific leadership team and organizational structure require deeper research using public filings and company website. The company is headed by Robert Hayes (CEO) and there is also Sanjay Nayar (CFO).

Top Products and Market Share

overview logo Key Offerings

  • Ultra-Low Waste Space Safety Syringes: These syringes are designed to minimize medication waste. Competitors include Becton Dickinson (BDX) and Smiths Medical. Specific market share data is difficult to determine without proprietary information but Sharps Tech is trying to disrupt this market.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is driven by technological advancements, regulatory requirements, and the increasing need for safer and more efficient healthcare solutions. The safety syringe market is growing due to concerns about needlestick injuries and the spread of infectious diseases.

Positioning

Sharps Technology Inc. is positioned as an innovator in the safety syringe market, focusing on reducing medication waste and improving safety for healthcare workers. Its competitive advantage lies in its patented ultra-low waste space design.

Total Addressable Market (TAM)

The global prefilled syringes market is estimated to be in the billions of dollars. Sharps Tech is positioned to capture a portion of this TAM with its specialized safety syringes.

Upturn SWOT Analysis

Strengths

  • Patented ultra-low waste space design
  • Focus on safety and reducing needlestick injuries
  • Potential for partnerships with pharmaceutical companies
  • Manufacturing scalability in Buffalo, NY

Weaknesses

  • Limited brand recognition compared to established players
  • Potential dependence on key partnerships
  • Financial performance and capital structure require significant growth
  • Limited product portfolio.

Opportunities

  • Growing demand for safety syringes
  • Expanding into new markets and applications (e.g., veterinary medicine)
  • Partnerships with pharmaceutical companies for prefilled syringes
  • Acquisition by a large player

Threats

  • Competition from established medical device companies (BDX)
  • Regulatory changes and compliance requirements
  • Economic downturn affecting healthcare spending
  • Patent litigation or challenges to intellectual property

Competitors and Market Share

competitor logo Key Competitors

  • Becton Dickinson (BDX)
  • Gerresheimer AG (GRRMF)
  • Smiths Medical (Part of ICU Medical (ICUI))

Competitive Landscape

Sharps Technology Inc. is a smaller player in the market compared to established giants like Becton Dickinson. It focuses on specific niche with patented design, competing on innovation and safety features, but faces challenges in scaling production and gaining market share against larger, more established competitors.

Growth Trajectory and Initiatives

Historical Growth: Historical growth trends require financial data over several years. Unable to provide without current financial statements.

Future Projections: Future growth projections are dependent on partnerships, market adoption, and manufacturing scalability. Analyst estimates are currently difficult to determine for this company.

Recent Initiatives: Recent strategic initiatives are centered around scaling manufacturing capacity and securing partnerships with pharmaceutical companies.

Summary

Sharps Technology Inc. is a small, innovative company focused on safety syringe technology. Its patented design and focus on reducing medication waste provide a competitive advantage. However, it faces significant challenges from larger, established players and needs to demonstrate its ability to scale production and secure key partnerships to achieve sustainable growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Industry Reports
  • Analyst Reports

Disclaimers:

The information provided is based on publicly available data and analyst estimates, and should not be considered as financial advice. Market conditions and company performance are subject to change. This analysis is for informational purposes only.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Sharps Technology Inc

Exchange NASDAQ
Headquaters Melville, NY, United States
IPO Launch date 2022-04-14
CEO -
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 55
Full time employees 55

Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York.